Ace Susung New Technology Fund 3, Dongyu Investment Co., Ltd and Nau Growth Capital PEF fund managed by Nau IB Capital, Investment Arm signed a stock definitive agreement to acquire 3.2% in Pharma Research Products Co., Ltd from Jung, Sang-Soo for KRW 16 billion.
March 19, 2018
Share
Ace Susung New Technology Fund 3, Dongyu Investment Co., Ltd and Nau Growth Capital PEF fund managed by Nau IB Capital, Investment Arm signed a stock definitive agreement to acquire 3.2% stake in Pharma Research Products Co., Ltd (KOSDAQ:A214450) from Jung, Sang-Soo for KRW 16 billion on March 12, 2018. As per terms, a total of 0.3 million shares will be acquired at KRW 53,046 per share. The consideration will be paid on closing. The deal is expected to close on March 21, 2018.
PharmaResearch Co Ltd, formerly Pharma Research Products Co Ltd, is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The Company mainly provides its products in domestic market.
Ace Susung New Technology Fund 3, Dongyu Investment Co., Ltd and Nau Growth Capital PEF fund managed by Nau IB Capital, Investment Arm signed a stock definitive agreement to acquire 3.2% in Pharma Research Products Co., Ltd from Jung, Sang-Soo for KRW 16 billion.
PHARMARESEARCH CO., LTD. 
